Skip to main content

Advertisement

SpringerLink
Log in

Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Reply to Lewis G and Maxwell AP [letter]

  • Letter
  • Published:
Diabetologia Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

ACEI:

ACE inhibitor

ARB:

Angiotensin II receptor blocker

References

  1. Lewis G, Maxwell AP (2014) Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Diabetologia doi:10.1007/s00125-014-3188-x

  2. Bell R, Glinianaia SV, Tennant PWG, Bilous RW, Rankin J (2012) Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia 55:936–947

    Article  CAS  Google Scholar 

  3. Tennant PWG, Glinianaia SV, Bilous RW, Rankin J, Bell R (2014) Pre-existing diabetes, maternal haemoglobin, and the risks of fetal and infant death: a population-based study. Diabetologia 57:285–294

    Article  CAS  PubMed  Google Scholar 

  4. Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD (2012) Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension 60:444–450

    Article  CAS  PubMed  Google Scholar 

  5. Cooper WO, Hernandez-Diaz S, Arbogast PG et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451

    Article  CAS  PubMed  Google Scholar 

  6. Li D-K, Yang C, Andrade S, Tavares V, Ferber J (2011) Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 343:d5931

    Article  PubMed Central  PubMed  Google Scholar 

  7. Walfisch A, Al-maawali A, Moretti ME et al (2011) Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers. J Obstet Gynaecol 31:465–472

    Article  CAS  PubMed  Google Scholar 

  8. Tennant PWG, Newham JJ, Bell R, Rankin J (2011) Studies of congenital anomalies should capture all cases, not just live births. BMJ (electronic letter). Available from www.bmj.com/rapid-response/2011/11/03/studies-congenital-anomalies-should-capture-all-cases-not-just-live-births. Accessed 4 February 2014

Download references

Duality of interest

All authors declare that they have no duality of interest.

Contribution statement

PWGT drafted the letter and SVG, RWB, JR and RB critically revised the draft. All authors declare that they read and approved the final version of the letter before submission.

Author information

Authors and Affiliations

  1. Institute of Health & Society, Newcastle University, Baddiley-Clark Building, Richardson Road, Newcastle upon Tyne, NE2 4AX, UK

    Peter W. G. Tennant, Svetlana V. Glinianaia, Judith Rankin & Ruth Bell

  2. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK

    Rudy W. Bilous

  3. James Cook University Hospital, South Tees NHS Trust, Middlesbrough, UK

    Rudy W. Bilous

  4. Regional Maternity Survey Office, Public Health England, Newcastle upon Tyne, UK

    Judith Rankin & Ruth Bell

Authors
  1. Peter W. G. Tennant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Svetlana V. Glinianaia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rudy W. Bilous
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Judith Rankin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ruth Bell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter W. G. Tennant.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tennant, P.W.G., Glinianaia, S.V., Bilous, R.W. et al. Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Reply to Lewis G and Maxwell AP [letter]. Diabetologia 57, 1084–1085 (2014). https://doi.org/10.1007/s00125-014-3191-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00125-014-3191-2

Keywords

Search

Navigation